Skip to main content
  • 186 Accesses

Abstract

The term “Hepatorenal Syndrome” (HRS) has been frequently used to refer to several episodes of simultaneous impairment of both renal and hepatic function.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arroyo V, Gines P, Gerbes AL et al (1996) Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 23 (1):164–176

    Article  PubMed  CAS  Google Scholar 

  2. Hecker R, Sherlock S (1956) Lancet ii:1121

    Article  Google Scholar 

  3. Papper S, Belsky J, Bleifer KH (1959) Ann Int Med 51:759

    Article  PubMed  CAS  Google Scholar 

  4. Epstein M, Ber DP, Hollenberg NK et al (1970) AM J Med 49:175

    Article  PubMed  CAS  Google Scholar 

  5. Koppel MH, Coburn JW, Mims MM et al (1969) N Engl J Med 280:1367

    Article  PubMed  CAS  Google Scholar 

  6. Iwatsuki S, Popovtzer M, Corman JL et al (1973) N Engl J Med 289:1155

    Article  PubMed  CAS  Google Scholar 

  7. Epstein M, Berk DP, Hollenberg NK et al (1970) Renal failure in patients with cirrhosis. The role of active vasoconstriction. Am J Med 49:175–185

    Article  PubMed  CAS  Google Scholar 

  8. Maxine A, Papadakis, Allen I et al (1987) Unpredictability of clinical evaluation of renal function in Cirrhosis. Prospective Study. Am J Med. Volume 82:945–952

    Article  Google Scholar 

  9. Papper S, Belsky JL, Bleifer KH (1959) Renal failure in Laennec’s cirrhosis of the liver. Description of clinical and laboratory features. Ann Intern Med 51:759–773

    Article  PubMed  CAS  Google Scholar 

  10. Kowalski HJ, Abelman WH (1953) The cardiac output at rest in Laennec’s cirrhosis. J Clin Invest 32:1025–1033

    Article  PubMed  CAS  Google Scholar 

  11. Vorobioff J, Bredfeldt JE, Groszmann RJ (1983) Hyperdynamic circulation in portal hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiology 244:G52-G57

    CAS  Google Scholar 

  12. Colombato LA, Albillos A, Groszmann J (1991) Temporal relationship of peripheral vasodilatation, plasma volume expansion and the hyperdynamic circulatory state in portalhypertensive rats. Hepatology 15:323–328

    Article  Google Scholar 

  13. Granger DN, Kevietys PR, Korthuis RJ et al (1989) Microcirculation of the intestinal mucosa. Wood JD (ed) Handbook of physiology. Baltimore: Waverly Press 1505–1474

    Google Scholar 

  14. Gallavan RH, Parks DA, Jacoboson ED (1989) Pathophysiology of gastrointestinal circulation. Wood JD (ed) Handbook of physiology. Baltimore: Waverly Press 1713–1732

    Google Scholar 

  15. Sikuler E, Kravetz D, Groszman RJ (1985) Evolution of portal-hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol 248:G618-G625

    PubMed  CAS  Google Scholar 

  16. Schrier RW, Arroyo V, Bernardi M et al (1988) Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8:1151–1157

    Article  PubMed  CAS  Google Scholar 

  17. Bichet DG, Van Putten VJ, Schrier RW (1982) Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis. N Engl J Med 307:1552–1557

    Article  PubMed  CAS  Google Scholar 

  18. Henriksen JH, Ring-Larsen H, Kanstrup IL et al (1984) Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis. Gut 25:1034–1043

    Article  PubMed  CAS  Google Scholar 

  19. DiBona GF (1984) Renal neural activity in hepatorenal syndrome. Kidney Int 25:841–853

    Article  PubMed  CAS  Google Scholar 

  20. Rodriguez-Martinez M, Sawin LL, DiBona GF (1995) Arterial and cardiopulmonary baroreflex control of renal nerve activity in cirrhosis. Am J Physiol. 1995 Jan; 268(1 Pt 2): R117–129

    Google Scholar 

  21. Soliz-Herruzo JA, Duran A, Favela V et al (1987) Hepatology 5:167

    Article  Google Scholar 

  22. Soliz-Herruzo JA, Duran A, Favela V et al (1987) Effect of lumbar sympathetic block on kidney function in cirrhotic patients with hepatorenal syndrome. Hepatology 7:167–173

    Google Scholar 

  23. Esler M, Dudley F, Jennings G et al (1992) Increased sympathetic nervous activitiy and the effects of its inhibition with clonidine in alcoholic cirrhosis. Ann Intern Med 116:446–455

    Article  PubMed  CAS  Google Scholar 

  24. Epstein M, Levinson R, Sancho J et al (1977) Characterization of the renin-aldosterone system in decompensated cirrhosis. Circ Res 41:818–829

    Article  PubMed  CAS  Google Scholar 

  25. Barnardo D, Summerskill WHJ, Strong CG et al (1970) Renal function, renal activity and endogenous vasoactive substances in cirrhosis. Am J Dig Dis 15:419–425

    Article  PubMed  CAS  Google Scholar 

  26. Schroeder ET, Eich RH, Smulyan H et al (1970) Plasma renin level in hepatic cirrhosis: Relation to functional renal failure. Am J Med 49:189–191

    Article  Google Scholar 

  27. Bernardi M, Fornale L, Di Marco C et al (1995) Hyperdynamic circulation of advanced cirrhosis: a re-appraisal based on posture-induced changes in hemodynamics. J Hepatol 22 (3):309–318

    Article  PubMed  CAS  Google Scholar 

  28. Yaniasigawa M, Kurihara H, Kimura S et al (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–415

    Article  Google Scholar 

  29. Vanhoutte PM (1988) The endothelium: modulator of vascular smooth muscle. N Engl J Med 319:512–513

    Article  PubMed  CAS  Google Scholar 

  30. Rees DD, Palmer RMJ, Moncada S (1989) Role of endothelium derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci 86:3375–3378

    Article  PubMed  CAS  Google Scholar 

  31. Palmer RMJ, Ferrige AG, Moncada S (1988) Vascular endothelial cells synthesize nitiric oxide from L-arginine. Nature 333:664–666

    Article  PubMed  CAS  Google Scholar 

  32. Vallance P, Moncada S (1991) Hyperdynamic circulation in cirrhosis: a role for nitric oxid. Lancet 337:776–778

    Article  PubMed  CAS  Google Scholar 

  33. Lumsden AB, Henderson JM, Kutner MH (1988) Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 8:232–236

    Article  PubMed  CAS  Google Scholar 

  34. Tilg H, Wilmer A, Vogel W et al (1992) Serum levels of cytokines in chronic liver diseases. Gastroenterology 103:264–274

    PubMed  CAS  Google Scholar 

  35. McCall TB, Boughton-Smith NK, Palmer RMJ et al (1989) Synthesis of nitric oxide from L-arginine by neutrophils: release and interaction with superoxide anion. Biochem J 261: 293–296

    PubMed  CAS  Google Scholar 

  36. Conrado M, Fernandez R, Prieto J et al (1995) Plasma levels of substance P in liver cirrhosis: Relationship to the activation of vasopressor systems and urinary sodium excretion. Hepatology 21:35–40

    Google Scholar 

  37. Burke GW, Cirocco R, Roth D et al (1993) Acitvated cytokine pattern in hepatorenal syndrome: Fall in levels after successful orthotopic liver transplantation. Transplantation Proceedings, Vol 25, No 2:1876–1877

    PubMed  CAS  Google Scholar 

  38. Laffi G, Foschi M, Masini E et al (1995) Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation. Hepatology 22:1666–1673

    PubMed  CAS  Google Scholar 

  39. Mathie RT, Ralevic V, Moore KP et al (1996) Mesenteric vasodilator responses in cirrhotic rats: a role for nitric oxide. Hepatology 23(1):130–136

    Article  PubMed  CAS  Google Scholar 

  40. Yaniasigawa M, Kurihara H, Kimura S et al (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–415

    Article  Google Scholar 

  41. Rabelink AJ, Kaasjager HAH, Boer P et al (1994) Effects of endothelin-1 on renal function in humans. Implications for physiology and pathophysiology. Kidney Int 46:376–381

    Article  PubMed  CAS  Google Scholar 

  42. Loutzenhiser R, Epstein M, Hayashi K et al (1990) Direct visualization of the effects of endothelin on the renal microvasculature. Am J Pysiol 258:F61-F68

    CAS  Google Scholar 

  43. Takenaka T, Forster H, Epstein M (1993) Protein Kinase C and calcium channel activation as determinants of renal vasoconstriction by angiotensin II and endothelin. Circ Res 73:743–750

    Article  PubMed  CAS  Google Scholar 

  44. Maddedu P, Troffa C, Glorioso N et al (1989) Effect of endothelin on regional hemodynamics and renal function in awake normotensive rats. J Cardiovasc Pharmacol 14:818–825

    Article  Google Scholar 

  45. Salo J, Francitorra A, Folio A et al (1995) Increased plasma endothelin in cirrhosis. J Hepatology 22(4):389–398

    Article  CAS  Google Scholar 

  46. Joost A, Bijlsma, Rabelink AJ et al (1995) L-arginine does not prevent the renal effects of endothelin in humans. J Am Soc Nephrol 5:1508–1516

    Google Scholar 

  47. Moore K, Wendon J, Frazer M et al (1992) Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med 327:1774–1778

    Article  PubMed  CAS  Google Scholar 

  48. Nozue T, Kobayashi A, Uemasu F et al (1995) Plasma endothelin-1 levels of children with cirrhosis. J Pediatr Gastroenterol Nutr. Vol 21(2):220–223

    Article  PubMed  CAS  Google Scholar 

  49. Zipser RD, Radvan GH, Kronberg IJ et al (1983) Gastroenterology 84:697

    PubMed  CAS  Google Scholar 

  50. Ros J, Claria J, Jiminez W et al (1995) Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis. Hepatology 22(3):915–920

    PubMed  CAS  Google Scholar 

  51. Perez-Ayuso RM, Arroyo V, Camps J et al (1984) Renal kallikrein excretion in cirrhotics with ascites: Relationship to renal hemodynamic. Hepatology 4:247–252

    Article  PubMed  CAS  Google Scholar 

  52. Laffi G, LaVilla G, Gentilini P (1994) Pathogenesis and Management of the Hepatorenal Syndrome. Seminars in Liver Disease. Vol 14(1):71–81

    Article  PubMed  CAS  Google Scholar 

  53. Epstein M (1995) Hepatorenal syndrome - Current concepts of pathophysiology and therapy. In: Bellomo R, Ronco C (eds) Update in intensive care and emergency medicine 20, Springer, pp 215–245

    Google Scholar 

  54. Mandal AK, Lansing M, Fahmy A (1982) Acute tubular necrosis in hepatorenal syndrome: An electron microscopic study. Am J Kidney Dis 2:368–374

    Google Scholar 

  55. Wamatz K, Schweigart U, Endres N et al (1994) Ornipressin in der Therapie des hepatoralen Syndroms. Intensivmed 32:287–293

    Google Scholar 

  56. Lenz K, Hortnagl H, Druml W et al (1989) Beneficial effect of 8-ornithin vasopressin on renal dysfunction in decompensated cirrhosis. Gut 30:90–96

    Article  PubMed  CAS  Google Scholar 

  57. Giostra E, Ruedin P et al (1995) Sustained effects on ornipressin in hepatorenal syndrome. J Hepatology 22(1):120–121

    Article  CAS  Google Scholar 

  58. Durkin R, Winter SM (1995) Reversal of hepatorenal syndrome with the combination of norepinephrine and dopamine. Critical Care Medicine. Vol 23(l):202–204

    Article  PubMed  CAS  Google Scholar 

  59. Rössle M, Richter GM, Nöldge G et al (1989) New non-operative treatment tor variceal hemorrhage. Lancet 2:153

    Article  PubMed  Google Scholar 

  60. Ochs A, Sellinger M, Haag K et al (1992) Transjugular intrahepatic portosystemic shunt for treatment of refractory ascites and hepatorenal syndrome: results of a pilot study. Gastroenterology 102:A863

    Google Scholar 

  61. Sturgis TM (1995) Hepatorenal syndrome: resolution after transjugular portosystemic shunt. J Clin Gastroenterol 20(3):141–143

    Article  Google Scholar 

  62. Epstein M (1978) Renal effects of head-out water immersion in man: Implications for an understanding of volume homeostasis. Physiol Rev 58:529–581

    PubMed  CAS  Google Scholar 

  63. Yersin B, Burnier M, Magnenat P (1995) Improvement of renal failure with repeated head-out water immersion in patients with hepatorenal syndrome associated with alcoholic hepatitis. Am J Nephrol 15(3):2

    Article  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Italia

About this paper

Cite this paper

Hammerle, A.F., Krafft, P., Tatschl, C. (1997). The Hepatorenal Syndrome. In: Gullo, A. (eds) Anaesthesia, Pain, Intensive Care and Emergency Medicine — A.P.I.C.E.. Springer, Milano. https://doi.org/10.1007/978-88-470-2296-6_45

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2296-6_45

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-3-540-75032-1

  • Online ISBN: 978-88-470-2296-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics